HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Johanne Martel-Pelletier Selected Research

Cyclooxygenase 2 (Cyclooxygenase-2)

4/2013Adult cartilage-specific peroxisome proliferator-activated receptor gamma knockout mice exhibit the spontaneous osteoarthritis phenotype.
1/2011Contribution of H3K4 methylation by SET-1A to interleukin-1-induced cyclooxygenase 2 and inducible nitric oxide synthase expression in human osteoarthritis chondrocytes.
7/2002Study of the role of leukotriene B()4 in abnormal function of human subchondral osteoarthritis osteoblasts: effects of cyclooxygenase and/or 5-lipoxygenase inhibition.
2/2002Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Johanne Martel-Pelletier Research Topics

Disease

95Osteoarthritis
02/2024 - 01/2002
32Knee Osteoarthritis
01/2023 - 02/2003
25Pain (Aches)
02/2024 - 02/2003
15Inflammation (Inflammations)
11/2023 - 12/2003
6Arthritis (Polyarthritis)
01/2013 - 01/2002
5Rheumatoid Arthritis
06/2020 - 12/2002
4Synovitis
01/2019 - 01/2010
4Fibrosis (Cirrhosis)
12/2017 - 01/2011
3Hypersensitivity (Allergy)
01/2024 - 11/2016
3Obesity
04/2022 - 01/2019
3Disease Progression
01/2019 - 01/2007
3Sclerosis
11/2012 - 01/2006
3Bone Resorption
09/2011 - 03/2004
2Hypertrophy
04/2022 - 05/2012
2Body Weight (Weight, Body)
01/2022 - 05/2012
2Osteoporosis
02/2016 - 02/2016
2Experimental Arthritis
07/2015 - 02/2011
2Osteophyte
06/2006 - 06/2003
1Joint Instability (Joint Laxity)
11/2023
1Knee Injuries (Knee Injury)
01/2023
1Reinjuries
01/2023
1Insulin Resistance
04/2022

Drug/Important Bio-Agent (IBA)

10Analgesics (Analgesic Drugs)IBA
02/2024 - 05/2008
9Chondroitin Sulfates (Chondroitin Sulfate)IBA
01/2017 - 07/2013
8Biomarkers (Surrogate Marker)IBA
12/2022 - 07/2002
7Glucosamine (Dona)IBA
10/2016 - 01/2007
7PPAR gammaIBA
04/2013 - 01/2002
7licofeloneIBA
08/2011 - 07/2002
7Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2005 - 03/2002
6Metalloproteases (Metalloproteinases)IBA
12/2017 - 10/2003
5Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2016 - 05/2008
5Dinoprostone (PGE2)FDA Link
05/2014 - 12/2003
5Peptide Hydrolases (Proteases)FDA Link
03/2014 - 06/2006
5Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
04/2013 - 07/2002
5CytokinesIBA
01/2011 - 01/2002
4NeuropeptidesIBA
11/2023 - 01/2016
4ProstaglandinsIBA
01/2023 - 07/2002
4Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2005
4diacereinIBA
12/2020 - 04/2010
4Celecoxib (Celebrex)FDA Link
12/2020 - 12/2010
4Complement Factor D (Factor D)IBA
01/2020 - 04/2016
4Interleukin-1 (Interleukin 1)IBA
01/2019 - 12/2002
4Ephrin-B2 (Ephrin B2)IBA
12/2017 - 12/2008
4strontium ranelate (protelos)IBA
03/2015 - 09/2011
4Matrix Metalloproteinases (MMPs)IBA
04/2013 - 10/2003
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2013 - 02/2002
4LigandsIBA
02/2011 - 01/2002
4Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
06/2006 - 07/2002
3LipocalinsIBA
12/2020 - 06/2013
3Prostaglandin D2IBA
12/2020 - 01/2017
3prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA
12/2020 - 06/2013
3AdipokinesIBA
01/2020 - 04/2016
3Iodoacetic AcidIBA
04/2019 - 01/2016
3Tramadol (K315)FDA LinkGeneric
01/2018 - 11/2016
3LeptinIBA
01/2017 - 04/2005
3Acetaminophen (Paracetamol)FDA LinkGeneric
02/2016 - 05/2008
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
06/2013 - 02/2002
3Matrix Metalloproteinase 13IBA
04/2013 - 02/2005
3Cathepsin KIBA
02/2013 - 03/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2013 - 01/2002
3Prostaglandins EIBA
09/2011 - 07/2002
3ChondroitinIBA
06/2011 - 01/2007
3Interleukin-1beta (Interleukin 1 beta)IBA
01/2010 - 03/2002
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2005 - 10/2002
2firocoxibIBA
02/2024 - 10/2022
2prostaglandin D2 receptorIBA
01/2023 - 01/2017
2Mitochondrial DNA (mtDNA)IBA
12/2022 - 01/2022
2SteroidsIBA
01/2022 - 02/2003
2Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
11/2019 - 01/2019
2Phosphatidylcholines (Phosphatidylcholine)IBA
11/2019 - 01/2019
2Hyaluronic Acid (Hyaluronan)IBA
01/2018 - 09/2017
2Gabapentin (Neurontin)FDA LinkGeneric
01/2018 - 02/2005
2Meloxicam (Mobic)FDA LinkGeneric
01/2018 - 11/2016
2DisintegrinsIBA
12/2017 - 04/2013
2EphB4 ReceptorIBA
11/2012 - 12/2008
2Naproxen (Naprosyn)FDA LinkGeneric
08/2011 - 12/2010
2tiludronic acid (tiludronate)FDA Link
06/2011 - 01/2011
2Diphosphonates (Bisphosphonates)IBA
06/2011 - 01/2011
2Interleukin-17 (Interleukin 17)IBA
12/2008 - 12/2002
2Transcription Factors (Transcription Factor)IBA
09/2007 - 05/2004
2PPAR-gamma AgonistsIBA
07/2007 - 02/2005
2Pioglitazone (Actos)FDA Link
07/2007 - 02/2005
2Therapeutic UsesIBA
02/2005 - 03/2004
2Lipoxygenase (Lipoxygenase-1)IBA
03/2004 - 03/2002
2EnzymesIBA
01/2004 - 10/2002
2Leukotriene B4IBA
07/2002 - 03/2002
1AllergensIBA
01/2024
1LipidsIBA
12/2023
1Phenylalanine (L-Phenylalanine)FDA Link
04/2022
1Branched-Chain Amino AcidsIBA
04/2022
1Insulin (Novolin)FDA Link
04/2022
1Tryptophan (L-Tryptophan)FDA Link
04/2022
1Glucose (Dextrose)FDA LinkGeneric
04/2022

Therapy/Procedure

11Knee Replacement Arthroplasty (Total Knee Replacement)
01/2023 - 08/2011
10Therapeutics
01/2022 - 06/2011
4Injections
01/2022 - 02/2003
4Replacement Arthroplasty
02/2016 - 01/2010
2Analgesia
02/2016 - 01/2016
1Arthroplasty
01/2023
1Diet Therapy (Therapy, Diet)
04/2022